S. Whitney Barnes

3.5k citations

20 papers · 1.2k indexed · 1 hit paper · h-index 12

Molecular Biology
Infectious Diseases top 5%
Epidemiology top 10%
Genetics top 10%
Public Health, Environmental and Occupational Health

Co-authors: John R. Walker David Alland Regina Wilson Kriti Arora Vinod Nair Elizabeth R. Fischer Kapil Tahlan Clifton E. Barry
Topics: Antibiotic Resistance in Bacteria (6 papers)Tuberculosis Research and Epidemiology (4 papers)Mycobacterium research and diagnosis (3 papers)
Cited by: Infectious Diseases Molecular Medicine Epidemiology
Journals: Proceedings of the National Academy of Sciences PLoS ONE PLoS Biology
Partner nations: United States Switzerland Canada

In The Last Decade

S. Whitney Barnes

19 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosis

2012 381 citations Kapil Tahlan, Regina Wilson et al. Antimicrobial Agents and Chemotherapy profile →

Peers

Countries citing papers authored by S. Whitney Barnes

Since Specialization

Citations

This map shows the geographic impact of S. Whitney Barnes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Whitney Barnes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Whitney Barnes more than expected).

Fields of papers citing papers by S. Whitney Barnes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Whitney Barnes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Whitney Barnes. The network helps show where S. Whitney Barnes may publish in the future.

Co-authorship network of co-authors of S. Whitney Barnes

This figure shows the co-authorship network connecting the top 25 collaborators of S. Whitney Barnes. A scholar is included among the top collaborators of S. Whitney Barnes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Whitney Barnes. S. Whitney Barnes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Triggering AHR resolves TGF-β1 induced fibroblast activation and promotes AT1 cell regeneration in alveolar organoids 2025 ·Communications Biology ·(unknown),S. D. Williams,Casey J. N. Mathison,Shanshan Yan,Bao Nguyen,Glenn C. Federe,(unknown),Joseph C. Siefert,(unknown),(unknown),S. Whitney Barnes,Frederick J. King,Brandon L. Taylor,John R. Walker,Rui Zhao,Jimmy Elliott,(unknown),B Fang,Rebekah S. Decker	0
2	A high throughput cell stretch device for investigating mechanobiology in vitro 2024 ·APL Bioengineering ·Stephen J. P. Pratt,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Truc T. Huynh,(unknown),S. Whitney Barnes,(unknown),James M. Pierce,J. Walker,James Mainquist,Frederick J. King,Jimmy Elliott,(unknown),Rebekah S. Decker	1
3	A high-throughput 3D cantilever array to model airway smooth muscle hypercontractility in asthma 2023 ·APL Bioengineering ·(unknown),(unknown),(unknown),(unknown),S. Whitney Barnes,(unknown),(unknown),(unknown),(unknown),(unknown),J. Walker,Minhua Qiu,(unknown),(unknown)	2
4	A high-throughput cigarette smoke-treated bronchosphere model for disease-relevant phenotypic compound screening 2023 ·PLoS ONE ·(unknown),(unknown),(unknown),Kaisheng Chen,S. Whitney Barnes,(unknown),(unknown),(unknown),Bin Fang,John R. Walker,William G. Barnes,(unknown)	1
5	“3D, human renal proximal tubule (RPTEC-TERT1) organoids ‘tubuloids’ for translatable evaluation of nephrotoxins in high-throughput” 2022 ·PLoS ONE ·(unknown),(unknown),(unknown),Frederick Yip-Kwai Lo,Jeffrey J. Sutherland,Guray Kuzu,Christopher J. Roberts,(unknown),S. Whitney Barnes,John R. Walker,Pia Kuss	3
6	Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2019 ·Virology ·Christopher S. McAllister,(unknown),Ellena Growcott,Zhong Yang,(unknown),Karen C. Wolff,Zhong Chen,Olga Tanaseichuk,G. Lelais,S. Whitney Barnes,Glenn C. Federe,(unknown),John R. Walker,Yingyao Zhou,Kelli Kuhen	10
7	Defects in Efflux ( oprM ), β-Lactamase ( ampC ), and Lipopolysaccharide Transport ( lptE ) Genes Mediate Antibiotic Hypersusceptibility of Pseudomonas aeruginosa Strain Z61 2019 ·Antimicrobial Agents and Chemotherapy ·Xiaoyu Shen,Nicole V. Johnson,(unknown),S. Whitney Barnes,John R. Walker,Angela Woods,David A. Six,Charles R. Dean	8
8	Mutations Reducing In Vitro Susceptibility to Novel LpxC Inhibitors in Pseudomonas aeruginosa and Interplay of Efflux and Nonefflux Mechanisms 2019 ·Antimicrobial Agents and Chemotherapy ·Adriana K. Jones,Ruth E. Caughlan,Angela Woods,(unknown),Lili Xie,S. Whitney Barnes,John R. Walker,Katherine V. Thompson,(unknown),Patrick S. Lee,Charles R. Dean	5
9	Target (MexB)- and Efflux-Based Mechanisms Decreasing the Effectiveness of the Efflux Pump Inhibitor D13-9001 in Pseudomonas aeruginosa PAO1: Uncovering a New Role for MexMN-OprM in Efflux of β-Lactams and a Novel Regulatory Circuit (MmnRS) Controlling MexMN Expression 2018 ·Antimicrobial Agents and Chemotherapy ·(unknown),Adriana K. Jones,(unknown),(unknown),Oleg Iartchouk,S. Whitney Barnes,John R. Walker,(unknown),Patrick S. Lee,Charles R. Dean	17
10	Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease 2015 ·PLoS Pathogens ·Shilpi Khare,Steven L. Roach,S. Whitney Barnes,Dominic Hoepfner,John R. Walker,Arnab K. Chatterjee,R. Jeffrey Neitz,Michelle R. Arkin,Case W. McNamara,(unknown),Yin Hwa Lai,Yue Fu,Valentina Molteni,Vince S. C. Yeh,James H. McKerrow,Richard Glynne,František Supek	39
11	Antituberculosis thiophenes define a requirement for Pks13 in mycolic acid biosynthesis 2013 ·Nature Chemical Biology ·Regina Wilson,Pradeep Kumar,Vijay Parashar,Catherine Vilchèze,Romain Veyron‐Churlet,Joel S. Freundlich,S. Whitney Barnes,John R. Walker,Michael J. Szymonifka,Emily Marchiano,Shubhada Shenai,Roberto Colangeli,William R. Jacobs,Matthew B. Neiditch,Laurent Kremer,David Alland	114
12	Identification of the Plasmodium berghei resistance locus 9 linked to survival on chromosome 9 2013 ·Malaria Journal ·Selina Bopp,Evelyn Rodrigo,Gonzalo E. González‐Páez,(unknown),S. Whitney Barnes,Clarissa Valim,James D. Watson,John R. Walker,Christian Schmedt,Elizabeth A. Winzeler	15
13	In vitro selection, via serial passage, of Clostridium difficile mutants with reduced susceptibility to fidaxomicin or vancomycin 2013 ·Journal of Antimicrobial Chemotherapy ·Jennifer A. Leeds,Meena Sachdeva,(unknown),S. Whitney Barnes,Alexey Ruzin	62
14	SQ109 Targets MmpL3, a Membrane Transporter of Trehalose Monomycolate Involved in Mycolic Acid Donation to the Cell Wall Core of Mycobacterium tuberculosisbreakdown → 2012 ·Antimicrobial Agents and Chemotherapy ·Kapil Tahlan,Regina Wilson,David B. Kastrinsky,Kriti Arora,Vinod Nair,Elizabeth R. Fischer,S. Whitney Barnes,John R. Walker,David Alland,Clifton E. Barry,Helena I. Boshoff	381
15	Mechanisms Decreasing In Vitro Susceptibility to the LpxC Inhibitor CHIR-090 in the Gram-Negative Pathogen Pseudomonas aeruginosa 2011 ·Antimicrobial Agents and Chemotherapy ·Ruth E. Caughlan,Adriana K. Jones,Angela M. DeLucia,Angela Woods,Lili Xie,Bing Ma,S. Whitney Barnes,John R. Walker,Elizabeth R. Sprague,Xia Yang,Charles R. Dean	42
16	Coresistance to Isoniazid and Ethionamide Maps to Mycothiol Biosynthetic Genes in Mycobacterium bovis 2011 ·Antimicrobial Agents and Chemotherapy ·Catherine Vilchèze,Yossef Av‐Gay,S. Whitney Barnes,Michelle H. Larsen,John R. Walker,Richard Glynne,William R. Jacobs	27
17	Whole-genome sequencing and microarray analysis of ex vivo Plasmodium vivax reveal selective pressure on putative drug resistance genes 2010 ·Proceedings of the National Academy of Sciences ·Neekesh V. Dharia,A. Taylor Bright,Scott J Westenberger,S. Whitney Barnes,Serge Batalov,Kelli Kuhen,Rachel Borboa,Glenn C. Federe,Colleen M. McClean,Joseph M. Vinetz,(unknown),Alejandro Llanos‐Cuentas,John W. Barnwell,John R. Walker,Elizabeth A. Winzeler	84
18	Efficacy and immunogenicity of Mycobacterium bovis ΔRD1 against aerosol M. bovis infection in neonatal calves 2009 ·Vaccine ·W. Ray Waters,Mitchell V. Palmer,Brian J. Nonnecke,Tyler C. Thacker,(unknown),D. Mark Estes,R. Glyn Hewinson,H. Martin Vordermeier,S. Whitney Barnes,Glenn C. Federe,John R. Walker,Richard Glynne,Tsungda Hsu,Brian Weinrick,Karolin Biermann,Michelle H. Larsen,William R. Jacobs	58
19	Use of a Dense Single Nucleotide Polymorphism Map for In Silico Mapping in the Mouse 2004 ·PLoS Biology ·Mathew T. Pletcher,(unknown),Serge Batalov,Andrew I. Su,S. Whitney Barnes,(unknown),Ron Korstanje,Xiao‐Song Wang,Deborah Nusskern,Molly A. Bogue,Richard Mural,Beverly Paigen,Tim Wiltshire	180
20	Genome-wide single-nucleotide polymorphism analysis defines haplotype patterns in mouse 2003 ·Proceedings of the National Academy of Sciences ·Tim Wiltshire,Mathew T. Pletcher,Serge Batalov,S. Whitney Barnes,Lisa M. Tarantino,M. Cooke,Hua Wu,(unknown),(unknown),Neal G. Copeland,Nancy A. Jenkins,Francis Kalush,Richard Mural,Richard Glynne,Steve A. Kay,Mark D. Adams,Colin Fletcher	193

About S. Whitney Barnes

S. Whitney Barnes is a scholar working on Molecular Medicine, Infectious Diseases and Genetics, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (6 papers), Tuberculosis Research and Epidemiology (4 papers) and Mycobacterium research and diagnosis (3 papers). The work is most often cited by research in Infectious Diseases (535 citations), Molecular Medicine (117 citations) and Epidemiology (407 citations). S. Whitney Barnes has collaborated with scholars based in United States, Switzerland and Canada. Frequent co-authors include John R. Walker, David Alland, Regina Wilson, Kriti Arora, Vinod Nair, Elizabeth R. Fischer, Kapil Tahlan, Clifton E. Barry, Helena I. Boshoff and David B. Kastrinsky. Their work appears in journals such as Proceedings of the National Academy of Sciences, PLoS ONE and PLoS Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact